293 related articles for article (PubMed ID: 34823750)
1. Anaphylaxis and Mast Cell Disorders.
Gülen T; Akin C
Immunol Allergy Clin North Am; 2022 Feb; 42(1):45-63. PubMed ID: 34823750
[TBL] [Abstract][Full Text] [Related]
2. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520
[TBL] [Abstract][Full Text] [Related]
3. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
Kačar M; Rijavec M; Šelb J; Korošec P
Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
[TBL] [Abstract][Full Text] [Related]
4. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.
Gulen T
Immunol Allergy Clin North Am; 2023 Nov; 43(4):681-698. PubMed ID: 37758406
[TBL] [Abstract][Full Text] [Related]
5. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
6. Fatal hymenoptera venom anaphylaxis by undetected clonal mast cell disorder: A better identification of high risk patients is needed.
Chatain C; Sedillot N; Thomas M; Pernollet M; Bocquet A; Boccon-Gibod I; Bouillet L; Leccia MT
Rev Med Interne; 2021 Dec; 42(12):869-874. PubMed ID: 34776279
[TBL] [Abstract][Full Text] [Related]
7. Hymenoptera Allergy and Mast Cell Activation Syndromes.
Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
[TBL] [Abstract][Full Text] [Related]
8. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone.
Šelb J; Rijavec M; Eržen R; Zidarn M; Kopač P; Škerget M; Bajrović N; Luzar AD; Park YH; Liu Y; Šerbec VČ; Zver S; Košnik M; Lyons JJ; Korošec P
J Allergy Clin Immunol; 2021 Aug; 148(2):621-626.e7. PubMed ID: 33753098
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
González-de-Olano D; Navarro-Navarro P; Muñoz-González JI; Sánchez-Muñoz L; Henriques A; de-Andrés-Martín A; Peralta-Arjonilla D; Mayado A; Jara-Acevedo M; García-Montero AC; Orfao A; Álvarez-Twose I
Allergy; 2024 Mar; 79(3):711-723. PubMed ID: 37818990
[TBL] [Abstract][Full Text] [Related]
10. Mastocytosis and related entities: a practical roadmap.
Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
[TBL] [Abstract][Full Text] [Related]
11. Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.
Zaghmout T; Maclachlan L; Bedi N; Gülen T
J Allergy Clin Immunol Pract; 2024 Mar; 12(3):753-761. PubMed ID: 38056692
[TBL] [Abstract][Full Text] [Related]
12. Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?
Golden DBK; Carter MC
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1117-1123. PubMed ID: 30961837
[TBL] [Abstract][Full Text] [Related]
13. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
Shin H; Lyons JJ
Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
[TBL] [Abstract][Full Text] [Related]
14. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092
[TBL] [Abstract][Full Text] [Related]
15. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.
Thomas EG; Thomas DJ
Immunol Allergy Clin North Am; 2023 Aug; 43(3):553-568. PubMed ID: 37394259
[TBL] [Abstract][Full Text] [Related]
16. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
[TBL] [Abstract][Full Text] [Related]
17. Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia.
O'Connell MP; Lyons JJ
Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):431-437. PubMed ID: 32769710
[TBL] [Abstract][Full Text] [Related]
18. How to diagnose mast cell activation syndrome: practical considerations.
Romantowski J; Górska A; Lange M; Nedoszytko B; Gruchała-Niedoszytko M; Niedoszytko M
Pol Arch Intern Med; 2020 Apr; 130(4):317-323. PubMed ID: 32096778
[TBL] [Abstract][Full Text] [Related]
19. The problem of anaphylaxis and mastocytosis.
Müller UR; Haeberli G
Curr Allergy Asthma Rep; 2009 Jan; 9(1):64-70. PubMed ID: 19063827
[TBL] [Abstract][Full Text] [Related]
20. Update on idiopathic anaphylaxis.
Calvani M
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27():52-53. PubMed ID: 35080312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
